Cervical cancer and duration of using hormonal contraceptives

Asia-Pacific Journal of Clinical Oncology

Volumn 4, Issue 2, 2008, Pages 107-112

  Nojomi, Marzieh ^a   Modaresgilani, Mitra ^c   Mozafari, Negar ^b   Erfany, Azadeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervix cancer; Duration; Hormonal oral contraceptives

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; IRAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; UTERINE CERVIX CANCER;

EID: 44949198353     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2008.00159.x     Document Type: Article

References (25)

1. Krivak TC, McBroom JW, Elkas JC. Novak's Gynecology, 13th edn. Lippincott Williams & Wilkins, Philadelphia, PA 2002; 1199-202.
2. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003; 5: 348-59.
3. Christopherson WM, Parker JE. Relation of cervical cancer to early marriage and childbearing. N Engl J Med 1965; 273: 235-9.
4. Winkelstein W Jr. Smoking and cervical cancer - current status: A review. Am J Epidemiol 1990; 131: 945-57.
5. Rotkin ID. Epidemiology of cancer of the cervix. 3. Sexual characteristics of a cervical cancer population. Am J Public Health Nations Health 1967; 57: 815-29.
6. Kessler II. Human cervical cancer as a venereal disease. Cancer Res 1976; 36: 783-91.
7. Meland MR, Flehinger BJ. Early incidence rates of precancerous cervical lesions in women using contraceptives. Gynecol Oncol 1973; 1: 290-4.
8. Ursin G, Peters RK, Henderson BE et al. Oral contraceptive use and adenocarcinoma of the cervix. Lancet 1994; 344: 1390-3.
9. Dyer O. Who links long term pill use to cervical cancer. BMJ 2002; 324: 808.
10. Morales MM. Socioeconomic factors and cervical cancer morality in Spain during the period 1989-1997. Arch Gynecol Obstet 2004; 2: 99-103.
11. Munoz N, Franceschi S, Bosetti C et al. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 2002; 9312: 1093-2002.
12. Green J, Berrington de Gonzalez A, Sweetland S et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: The UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003; 11: 2078-86.
13. Kjellberg L, Hallmans G, Ahren AM et al. Smoking, diet, pregnancy and oral contraceptive use as a risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 7: 1332-8.
14. Sierra-Torres CH, Tyring SK, Au WW. Risk contribution of sexual behavior and cigarette smoking to cervical neoplasia. Int J Gynecol Cancer 2003; 5: 617-25.
15. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996; 16: 1030-7.
16. McMichael AJ, Hiller JE. Pills, partners and preventive prospects: in-situ cancer of the cervix. Med J Aust 1989; 15: 114-16.
17. Juneja A, Sehgal A, Mitra AB, Pandey A. A survey on risk factors associated with cervical cancer. Indian J Cancer 2003; 1: 15-22.
18. Cuzick J, Sasieni P, Singer A. Risk factors for invasive cervix cancer in young women. Eur J Cancer 1996; 32A: 836-41.
19. Deacon J, Evans CD, Yule R et al. Sexual behaviour and smoking as determinants cervical HPV infection and of CIN3 among those infected: A case-control study nested within the Manchester cohort. Br J Cancer 2003; 83: 1565-72.
20. Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L. Hormonal and barrier methods of contraception, oncogenic human papilloma virus, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 2001; 10: 441-9.
21. Hildesheim A, Herrero R, Castle P et al. HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br J Cancer 2001; 84: 1219-26.
22. Moreno V, Bosch FX, Munoz N et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 2002; 359: 1058-92.
23. Smith JS, Green J, Berrington de Gonzalez A et al. Cervical cancer and use of hormonal contraceptives: A systematic review. Lancet 2003; 361: 1159-67.
24. Berrington A, Jha PK, Peto J, Green J, Hermon C. Oral contraceptives and cervical cancer. Lancet 2002; 360: 410.
25. Ngelangel C, Munoz N, Bosch FX etal. Causes of cervical cancer in the Philippines: A case-control study. J Natl Cancer Inst 1998; 90: 43-9.